| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Article |
Division of Cellular and Molecular Pharmacology, Department of Experimental Medical Science, Lund University, Lund, Sweden (L.M.F.L.-L.); Centre de Recherche, Centre Hospitalier Universitaire de Quebec, Quebec, Canada (F.M.); Institute of Biochemistry II, Johann Wolfgang Goethe University School of Medicine, Frankfurt, Germany (W.M.-E.); Departments of Medicinal Chemistry and Neuroscience, Merck Research Laboratories, West Point, Pennsylvania (D.J.P.); and Department of Medicine, Veterans Affairs Medical Center and University of California, San Diego, California (B.L.Z.)
Abstract
Abstract I. A Short History of Kinins and Their Receptors II. Pharmacological Classification of Kinin Receptor Subtypes A. Peptide Agonists B. Peptide Antagonists C. Nonpeptide Ligands 1. B2 Receptor Agonists. 2. B2 Receptor Antagonists. 3. B1 Receptor Antagonists. III. Structural Aspects of Kinin Receptors and Their Genes A. Organization and Structure of the Receptor Genes B. Receptors and Their Post-Translational Modifications 1. Glycosylation. 2. Disulfide Bridging. 3. Acylation. 4. Phosphorylation. C. Agonist and Antagonist Binding Sites in the Receptors 1. B2 Receptor Agonists. 2. B2 Receptor Antagonists. 3. B1 Receptor Agonists. 4. B1 Receptor Antagonists. D. Evolutionary Aspects of Kinin Receptors IV. Molecular and Cellular Aspects of Kinin Receptor Signaling and Regulation A. Agonist-Dependent and -Independent Mechanisms of Receptor Activation B. Receptor Cellular Signaling Pathways C. Protein-Protein Interactions in Receptor Signaling D. Receptor Desensitization E. Cellular Distribution and Trafficking of Receptors V. Long-Term Regulation of Kinin Receptors by Proinflammatory Factors A. Postisolation Induction of the B1 Receptor B. Proinflammatory Cytokines and Growth Factors C. Agonists D. Ras and B2 Receptors E. Regulatory Elements in the Gene Promoters F. mRNA Stability VI. Distribution and Pathophysiological Function of Kinin Receptors A. Circulation and Renal Function B. Inflammation C. Pain and Neurology D. Diabetes VII. Kinin Receptors and Human Disease A. Cardiovascular Disease 1. Left Ventricular Hypertrophy and Cardiomyopathy. 2. Vascular Tone. 3. Hypertension. B. Renal Disease C. Airway Disease D. Neurological Disease E. Cancer F. Other Disease States G. Caveats VIII. Kinin Receptors and Drug Development A. Pain B. Cardiovascular Function C. Airway Function D. Cancer IX. Epilogue
Kinins are proinflammatory peptides that mediate numerous vascular and pain responses to tissue injury. Two pharmacologically distinct kinin receptor subtypes have been identified and characterized for these peptides, which are named B1 and B2 and belong to the rhodopsin family of G protein-coupled receptors. The B2 receptor mediates the action of bradykinin (BK) and lysyl-bradykinin (Lys-BK), the first set of bioactive kinins formed in response to injury from kininogen precursors through the actions of plasma and tissue kallikreins, whereas the B1 receptor mediates the action of des-Arg9-BK and Lys-des-Arg9-BK, the second set of bioactive kinins formed through the actions of carboxypeptidases on BK and Lys-BK, respectively. The B2 receptor is ubiquitous and constitutively expressed, whereas the B1 receptor is expressed at a very low level in healthy tissues but induced following injury by various proinflammatory cytokines such as interleukin-1
. Both receptors act through G
q to stimulate phospholipase C followed by phosphoinositide hydrolysis and intracellular free Ca2+ mobilization and through Gi to inhibit adenylate cyclase and stimulate the mitogen-activated protein kinase pathways. The use of mice lacking each receptor gene and various specific peptidic and nonpeptidic antagonists have implicated both B1 and B2 receptors as potential therapeutic targets in several pathophysiological events related to inflammation such as pain, sepsis, allergic asthma, rhinitis, and edema, as well as diabetes and cancer. This review is a comprehensive presentation of our current understanding of these receptors in terms of molecular and cell biology, physiology, pharmacology, and involvement in human disease and drug development.
This article has been cited by other articles:
|
|
 |
|
  L. Sanchez de Miguel, S. Neysari, S. Jakob, M. Petrimpol, N. Butz, A. Banfi, C. E. Zaugg, R. Humar, and E. J. Battegay B2-kinin receptor plays a key role in B1-, angiotensin converting enzyme inhibitor-, and vascular endothelial growth factor-stimulated in vitro angiogenesis in the hypoxic mouse heart Cardiovasc Res, October 1, 2008; 80(1): 106 - 113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Sanden, J. Enquist, S. H. Bengtson, H. Herwald, and L. M. F. Leeb-Lundberg Kinin B2 Receptor-Mediated Bradykinin Internalization and Metalloendopeptidase EP24.15-Dependent Intracellular Bradykinin Degradation J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 24 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Mori, R. C. Araujo, F. C.G. Reis, D. G. Sgai, R. G. Fonseca, C. C. Barros, V. F. Merino, M. Passadore, A. M. Barbosa, B. Ferrari, et al. Kinin B1 Receptor Deficiency Leads to Leptin Hypersensitivity and Resistance to Obesity Diabetes, June 1, 2008; 57(6): 1491 - 1500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Andre, D Gazzieri, E Bardella, J Ferreira, M A Mori, V V Saul, M Bader, J B Calixto, R De Giorgio, R Corinaldesi, et al. Expression and functional pharmacology of the bradykinin B1 receptor in the normal and inflamed human gallbladder Gut, May 1, 2008; 57(5): 628 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wang, Y. Dai, T. Fukuoka, H. Yamanaka, K. Kobayashi, K. Obata, X. Cui, M. Tominaga, and K. Noguchi Phospholipase C and protein kinase A mediate bradykinin sensitization of TRPA1: a molecular mechanism of inflammatory pain Brain, May 1, 2008; 131(5): 1241 - 1251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhang, F. Tan, Y. Zhang, and R. A. Skidgel Carboxypeptidase M and Kinin B1 Receptors Interact to Facilitate Efficient B1 Signaling from B2 Agonists J. Biol. Chem., March 21, 2008; 283(12): 7994 - 8004. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. L. M. Quintao, G. F. Passos, R. Medeiros, A. F. Paszcuk, F. L. Motta, J. B. Pesquero, M. M. Campos, and J. B. Calixto Neuropathic Pain-Like Behavior after Brachial Plexus Avulsion in Mice: The Relevance of Kinin B1 and B2 Receptors J. Neurosci., March 12, 2008; 28(11): 2856 - 2863. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Lim, L. Fedrizzi, M. Tartari, C. Zuccato, E. Cattaneo, M. Brini, and E. Carafoli Calcium Homeostasis and Mitochondrial Dysfunction in Striatal Neurons of Huntington Disease J. Biol. Chem., February 29, 2008; 283(9): 5780 - 5789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. O. Mosnier, X. V. Yang, and J. H. Griffin Activated Protein C Mutant with Minimal Anticoagulant Activity, Normal Cytoprotective Activity, and Preservation of Thrombin Activable Fibrinolysis Inhibitor-dependent Cytoprotective Functions J. Biol. Chem., November 9, 2007; 282(45): 33022 - 33033. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhang, V. Brovkovych, S. Brovkovych, F. Tan, B.-S. Lee, T. Sharma, and R. A. Skidgel Dynamic Receptor-dependent Activation of Inducible Nitric-oxide Synthase by ERK-mediated Phosphorylation of Ser745 J. Biol. Chem., November 2, 2007; 282(44): 32453 - 32461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-T. Bawolak, L. Gera, G. Morissette, J. M. Stewart, and F. Marceau B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-bradykinin) Is an Inactivation-Resistant Agonist of the Bradykinin B2 Receptor Derived from the Peptide Antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin): Pharmacologic Profile and Effective Induction of Receptor Degradation J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 534 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Duchene, F. Lecomte, S. Ahmed, C. Cayla, J. Pesquero, M. Bader, M. Perretti, and A. Ahluwalia A Novel Inflammatory Pathway Involved in Leukocyte Recruitment: Role for the Kinin B1 Receptor and the Chemokine CXCL5 J. Immunol., October 1, 2007; 179(7): 4849 - 4856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Hawkinson, B. G. Szoke, A. W. Garofalo, D. S. Hom, H. Zhang, M. Dreyer, J. Y. Fukuda, L. Chen, B. Samant, S. Simmonds, et al. Pharmacological, Pharmacokinetic, and Primate Analgesic Efficacy Profile of the Novel Bradykinin B1 Receptor Antagonist ELN441958 J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 619 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Berg, A. M. Patwardhan, T. A. Sanchez, Y. M. Silva, K. M. Hargreaves, and W. P. Clarke Rapid Modulation of {micro}-Opioid Receptor Signaling in Primary Sensory Neurons J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 839 - 847. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cayla, M. Todiras, R. Iliescu, V. V. Saul, V. Gross, B. Pilz, G. Chai, V. F. Merino, J. B. Pesquero, O. C. Baltatu, et al. Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension FASEB J, June 1, 2007; 21(8): 1689 - 1698. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Shen, L. M. Harrison-Bernard, A. J. Fuller, V. Vanderpool, Z. Saifudeen, and S. S. El-Dahr The Bradykinin B2 Receptor Gene Is a Target of Angiotensin II Type 1 Receptor Signaling J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1140 - 1149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Moreau, M.-T. Bawolak, G. Morissette, A. Adam, and F. Marceau Role of Nuclear Factor-{kappa}B and Protein Kinase C Signaling in the Expression of the Kinin B1 Receptor in Human Vascular Smooth Muscle Cells Mol. Pharmacol., March 1, 2007; 71(3): 949 - 956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. G. Pelorosso, A. V. Halperin, A. M. Palma, W. Nowak, A. E. Errasti, and R. P. Rothlin Neutral Endopeptidase Up-Regulation in Isolated Human Umbilical Artery: Involvement in Desensitization of Bradykinin-Induced Vasoconstrictor Effects J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 713 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Enquist, C. Skroder, J. L. Whistler, and L.M. F. Leeb-Lundberg Kinins Promote B2 Receptor Endocytosis and Delay Constitutive B1 Receptor Endocytosis Mol. Pharmacol., February 1, 2007; 71(2): 494 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Imamura, H. Kobayashi, R. Khan, H. Nitta, and K. Okamoto Induction of Vascular Leakage and Blood Pressure Lowering through Kinin Release by a Serine Proteinase from Aeromonas sobria J. Immunol., December 15, 2006; 177(12): 8723 - 8729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Monteiro, V. Schmitz, E. Svensjo, R. T. Gazzinelli, I. C. Almeida, A. Todorov, L. B. de Arruda, A. C. T. Torrecilhas, J. B. Pesquero, A. Morrot, et al. Cooperative Activation of TLR2 and Bradykinin B2 Receptor Is Required for Induction of Type 1 Immunity in a Mouse Model of Subcutaneous Infection by Trypanosoma cruzi J. Immunol., November 1, 2006; 177(9): 6325 - 6335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Chachisvilis, Y.-L. Zhang, and J. A. Frangos G protein-coupled receptors sense fluid shear stress in endothelial cells PNAS, October 17, 2006; 103(42): 15463 - 15468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Bengtson, S. B. Phagoo, A. Norrby-Teglund, L. Pahlman, M. Morgelin, B. L. Zuraw, L. M. F. Leeb-Lundberg, and H. Herwald Kinin receptor expression during Staphylococcus aureus infection Blood, September 15, 2006; 108(6): 2055 - 2063. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Fang, A. M. Ferrie, N. H. Fontaine, J. Mauro, and J. Balakrishnan Resonant Waveguide Grating Biosensor for Living Cell Sensing Biophys. J., September 1, 2006; 91(5): 1925 - 1940. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Fan, J. Stefkova, and S. S. El-Dahr Susceptibility to metanephric apoptosis in bradykinin B2 receptor null mice via the p53-Bax pathway Am J Physiol Renal Physiol, September 1, 2006; 291(3): F670 - F682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Nakano, C.-J. Kwak, K. Fujii, K. Ikemura, A. Satake, M. Ohkita, M. Takaoka, Y. Ono, M. Nakai, N. Tomimori, et al. Sesamin Metabolites Induce an Endothelial Nitric Oxide-Dependent Vasorelaxation through Their Antioxidative Property-Independent Mechanisms: Possible Involvement of the Metabolites in the Antihypertensive Effect of Sesamin J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 328 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ehrenfeld, C. Millan, C. E. Matus, J. E. Figueroa, R. A. Burgos, F. Nualart, K. D. Bhoola, and C. D. Figueroa Activation of kinin B1 receptors induces chemotaxis of human neutrophils J. Leukoc. Biol., July 1, 2006; 80(1): 117 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Sayah, R. Medeiros, E. S. Fernandes, M. M. Campos, and J. B. Calixto Mechanisms Underlying Lipopolysaccharide-Induced Kinin B1 Receptor Up-Regulation in the Pig Iris Sphincter in Vitro Mol. Pharmacol., May 1, 2006; 69(5): 1701 - 1708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Gera, J.-P. Fortin, A. Adam, J. M. Stewart, and F. Marceau Discovery of a Dual-Function Peptide That Combines Aminopeptidase N Inhibition and Kinin B1 Receptor Antagonism J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 300 - 308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-P. Fortin, E. K. Dziadulewicz, L. Gera, and F. Marceau A Nonpeptide Antagonist Reveals a Highly Glycosylated State of the Rabbit Kinin B1 Receptor Mol. Pharmacol., April 1, 2006; 69(4): 1146 - 1157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Rodriguez, P. De la Cerda, E. Collyer, V. Decap, C. P. Vio, and V. Velarde Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H30 - H36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Moreau, P. Dubreuil, G. Molinaro, M. Chagnon, W. Muller-Esterl, Y. Lepage, F. Marceau, and A. Adam Expression of Metallopeptidases and Kinin Receptors in Swine Oropharyngeal Tissues: Effects of Angiotensin I-Converting Enzyme Inhibition and Inflammation J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1065 - 1074. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. F. De Godoy and S. Rattan Autocrine regulation of internal anal sphincter tone by renin-angiotensin system: comparison with phasic smooth muscle Am J Physiol Gastrointest Liver Physiol, December 1, 2005; 289(6): G1164 - G1175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Valenti, C. Cialdai, S. Giuliani, A. Lecci, M. Tramontana, S. Meini, L. Quartara, and C. A. Maggi MEN16132, a Novel Potent and Selective Nonpeptide Kinin B2 Receptor Antagonist: In Vivo Activity on Bradykinin-Induced Bronchoconstriction and Nasal Mucosa Microvascular Leakage in Anesthetized Guinea Pigs J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 616 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Wettschureck and S. Offermanns Mammalian G Proteins and Their Cell Type Specific Functions Physiol Rev, October 1, 2005; 85(4): 1159 - 1204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-P. Fortin, L. Gera, J. Bouthillier, J. M. Stewart, A. Adam, and F. Marceau Endogenous Aminopeptidase N Decreases the Potency of Peptide Agonists and Antagonists of the Kinin B1 Receptors in the Rabbit Aorta J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1169 - 1176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Renne, K. Schuh, and W. Muller-Esterl Local Bradykinin Formation Is Controlled by Glycosaminoglycans J. Immunol., September 1, 2005; 175(5): 3377 - 3385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Phagoo, K. Reddi, B. J. Silvallana, L. M. F. Leeb-Lundberg, and D. Warburton Infection-Induced Kinin B1 Receptors in Human Pulmonary Fibroblasts: Role of Intact Pathogens and p38 Mitogen-Activated Protein Kinase-Dependent Signaling J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1231 - 1238. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
 |
 |
 |
|
 |
 |
 |
